Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? - Wikidata - wikimedia - TriplyDB

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

http://www.wikidata.org/entity/Q34534796

about

ESUR prostate MR guidelines 2012 Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine The current and future role of magnetic resonance imaging in prostate cancer detection and management Current role of multiparametric magnetic resonance imaging for prostate cancer Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer Diffusion Magnetic Resonance Imaging: What Water Tells Us about Biological Tissues The role of magnetic resonance imaging in the diagnosis and management of prostate cancer Multiparametric magnetic resonance imaging of the prostate: current concepts Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies Functional MRI in prostate cancer detection Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS Multiparametric-MRI in diagnosis of prostate cancer Integration of multiparametric MRI into active surveillance of prostate cancer.Oncologic Angiogenesis Imaging in the clinic---how and why.Correlated diffusion imaging.Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study.Advances in diffusion-weighted imaging Diffusion tensor imaging in abdominal organs.Information-based ranking of 10 compartment models of diffusion-weighted signal attenuation in fixed prostate tissue.Diffusion magnetic resonance imaging: A molecular imaging tool caught between hope, hype and the real world of "personalized oncology"Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.Microscopic diffusion anisotropy in formalin fixed prostate tissue: preliminary findings.Magnetic resonance microscopy of prostate tissue: How basic science can inform clinical imaging development Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment Diffusion-weighted MRI and its role in prostate cancer.Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.Prostate biopsy for the interventional radiologist DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts.High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness Is visual registration equivalent to semiautomated registration in prostate biopsy?Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research.Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations.Promise and pitfalls of quantitative imaging in oncology clinical trials.Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software.Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device

P2860

Q24620926-7B20F60C-BAA2-4A4A-85A9-C69D4B24E689 Q26749961-C62FCD21-391F-43F3-9802-192D2E8F8554 Q26773645-E30C70B5-C76C-4238-AF47-AF4EF6233CBA Q26774839-334AA637-EC37-47B6-9263-49FBD274BE44 Q26776478-F601C483-7075-4CA3-AEB9-68AD9967F019 Q26800153-53B2D029-6D51-4A8F-AA1C-CF7D7B818FF5 Q26849794-C0C2483E-7853-4916-AB4B-A854A0A277D4 Q26859699-F2DBAC12-1258-411E-9B55-4C03E69BB0AE Q27001055-16B60A78-0B2E-4CED-A6E8-A9A97F45AA44 Q27009471-159E69CB-3E99-426B-9B9B-2527CEDF6565 Q27027567-1425F21F-930A-4172-B1D9-BD86F682AEC8 Q28068102-6D4DD34B-2AF9-4C2C-B5A7-AE7EB1690F16 Q28081873-608BB35A-C21D-45CA-829F-81FEC591B8CC Q30249514-A54717FC-66C4-4B7C-B894-A549CB5FF812 Q30472751-A0237D09-46BC-47F1-8561-D9742D27C7D6 Q30660148-99BE6196-CAC5-4EB1-828A-7DF100305098 Q30923900-71E030C6-7FA8-4C4E-AF7D-AC990CEBFE69 Q30946553-1A6A63AC-2D72-486F-AE19-B622E34438F5 Q31021118-68EE06E2-0B95-434D-8669-B5DE41599CB5 Q31061248-1A68E638-559E-4AED-9350-9699E0549D87 Q33854846-063C18D0-6E6A-423A-BEED-64637C37B109 Q33870183-FA692953-B0A1-4CB5-B028-7B876B07F654 Q34144375-C06EC90B-3BAB-402B-99DB-11D9A2731DF3 Q34247368-04288C82-1C9D-47D9-9647-C2710A705A5B Q34475350-8F4741F3-8387-4792-A5BF-13F508D9DCFD Q34742733-A5E99FFE-DC75-4FF8-841F-C990C7FDA9D0 Q34893798-0CC47044-0969-4C62-9A9F-A6DA9FC996B6 Q35019408-F11841C7-C302-4B03-93B3-F17F6D48E93D Q35094559-60461268-ED70-4E31-8BE6-82729789D196 Q35164071-672A2DCA-60C1-4D89-B7B8-04F59F54F7F4 Q35187764-77ACA324-9ED5-46AB-B458-89C7EA8A5F4E Q35354750-34713F2F-2F87-4651-A99B-F25D5E533039 Q35722781-DFF427E6-0644-4C0B-A182-600A3B1477D7 Q35772886-834C7901-7453-4DA5-910C-FD8B23D0E0C4 Q36146827-5F24D7EA-740A-4A92-9E6E-5AFE9B90F57F Q36303765-7F5DB3F9-2E53-44C6-A4B8-95EF61ED2B5E Q36346204-F54B6797-4119-4F7D-AC1E-277FD96ADAE6 Q36417640-CDDC3341-80D4-418E-9393-EA73AFD7D09C Q36465803-13F49E1B-7B6A-45B6-B845-388866B9B524 Q36579232-09560D16-7DDD-48DE-BCE1-64E7B6E1F0D2

P2860

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

http://www.wikidata.org/entity/Q34534796

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@ast

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@en

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@nl

type

label

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@ast

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@en

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@nl

prefLabel

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@ast

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@en

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@nl

P1433

Q34534796-4C01D534-B949-4F14-BD19-708C66D7C4ED

P1476

Q34534796-54C5F3CD-801D-4C7A-8521-3E66773C507E

P2093

Q34534796-0A6805DB-67ED-46F2-865F-D5687EA607B2

Q34534796-155468C2-FA71-4D06-A5B9-9C8504CB553F

Q34534796-1CA84D0C-4FB3-4751-A03E-8D1ABE471729

Q34534796-2CA8913A-AD1B-49C4-81EF-A3D8BBC15636

Q34534796-44C14FBF-A151-43F9-88FA-A4DF250E6B16

Q34534796-6E51F23A-80C3-45F8-A043-DB5C0AF41FBB

Q34534796-9515EB2D-9147-4DD7-9E49-D387CAECBE77

Q34534796-A49ADCE8-DC9C-4867-B850-9BF08D66B223

Q34534796-B804339B-37F0-49C5-92FA-1649C323FF63

Q34534796-CBEFC068-8515-4D20-B0CB-D4967633F49D

P2860

Q34534796-0773C84C-A8BD-4EDB-9507-8363BF102316

Q34534796-0F26682F-4D3C-441D-A91B-8E2D94821F10

Q34534796-28E5A54C-CFA6-4E85-AA5F-1A2BFCF8EDB5

Q34534796-2EF45221-785A-468C-A39F-8E72C8E68CAD

Q34534796-34C0A572-1E00-40FF-A977-7790CDBAFE2A

Q34534796-3D10E71F-A259-48CD-9896-82D94E4D276A

Q34534796-4CEE20B1-C506-4A14-B5B5-140AE3702A1B

Q34534796-54E915F0-8CB8-459E-B7F8-8FCD6AC801A4

Q34534796-5F8787A6-F46E-49CA-BF3E-EADE8D871D7C

Q34534796-64F5E74B-2565-4523-BE8A-86A6BE0A5C4A

P304

Q34534796-55D37290-940F-4D52-861B-69CB8F036830

P31

Q34534796-2E34A3A2-44F8-4A07-86CA-EC962E864A50

P356

Q34534796-8547EEAC-EFCA-44CA-B707-1CB9FF6B3870

P407

Q34534796-5E06375D-F3AE-49DD-944E-01C104EED506

P433

Q34534796-ACE0212C-84E5-4495-BF2A-3664A038A1E9

P478

Q34534796-49387691-9137-44A6-AE75-866E7A63B259

P50

Q34534796-31740BB5-CC9E-46B7-AFA8-9442C6E3A3E6

Q34534796-3E14D665-F990-4E24-93CD-68A2B7187E33

P577

Q34534796-B2E9CCFA-D9EF-45EB-B2C0-8D63606F36E0

P5875

Q34534796-6CC119C4-0F70-4E65-AC15-A504C21B0B0D

P698

Q34534796-FD97AC83-DE72-4438-96D6-2C19CB91A330

P932

Q34534796-DF1F3CCB-6311-47E9-88D5-12F00A69DA3B

P356

RADIOL.10100667

P1433

P1476

Is apparent diffusion coeffici ...... are visible on 3-T MR images?

@en

P2093

Angelo A Baccala

http://www.w3.org/2001/XMLSchema#string

Ardeshir R Rastinehad

http://www.w3.org/2001/XMLSchema#string

Baris Turkbey

http://www.w3.org/2001/XMLSchema#string

Joanna H Shih

http://www.w3.org/2001/XMLSchema#string

Jochen Kruecker

http://www.w3.org/2001/XMLSchema#string

Julia Locklin

http://www.w3.org/2001/XMLSchema#string

Marcelino Bernardo

http://www.w3.org/2001/XMLSchema#string

Maria J Merino

http://www.w3.org/2001/XMLSchema#string

Peter A Pinto

http://www.w3.org/2001/XMLSchema#string

Peter L Choyke

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.

Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.

Radical prostatectomy versus watchful waiting in early prostate cancer.

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.

Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.

Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.

Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.

P304

488-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.10100667

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

258

http://www.w3.org/2001/XMLSchema#string

P50

Bradford J. Wood

P577

2010-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49701607

http://www.w3.org/2001/XMLSchema#string

P698

21177390

http://www.w3.org/2001/XMLSchema#string

P932

3029887

http://www.w3.org/2001/XMLSchema#string